G6PD and cancer: Zara et al. [90] identified M. procera extracts as potential inhibitors of cancer cell proliferation (IC50 = 6.18 μg/mL) and, through molecular docking studies targeting glucose-6-phosphate dehydrogenase (G6PD), identified p-hydroxybenzoate, quercetin, and syringic acid as compounds with strong binding affinity to G6PD.